Workman Craig D, Thrasher T Adam
Department of Health and Human Performance, University of Houston, 3855 Holman Street, 104 Garrison Gym, Houston, TX, 77204, USA; Center for Neuromotor and Biomechanics Research, 4733 Wheeler Ave, Houston, TX, 77204 USA.
Gait Posture. 2019 May;70:98-103. doi: 10.1016/j.gaitpost.2019.02.015. Epub 2019 Feb 22.
Studies have shown that dual-task standing balance in Parkinson's disease (PD) is significantly diminished. Additionally, it is well accepted that dopaminergic medication improves dynamic balance (Berg Balance Scale, mini-BESTest), but standing balance (force platform posturography) may suffer. What remains unknown is how dopaminergic medication influences standing balance automaticity in PD.
Does dopaminergic medication improve standing balance automaticity during a phoneme monitoring dual-task in PD?
This was a cross-sectional study. Sixteen subjects with PD completed single- and dual-task standing with eyes open and eyes closed for 3 min each in off and on medication states. 95% confidence ellipse area, anterior-posterior sway velocity, medial-lateral sway velocity, and integrated time to boundary were calculated. Data were analyzed with a repeated measures ANOVA.
Dopaminergic medication significantly increased ellipse area (p = 0.002) and decreased the performance on the secondary task (p = 0.004). Different eyes conditions (open vs. closed) significantly increased both sway velocities (anterior-posterior = p < 0.001, medial-lateral = p < 0.001), and increased integrated time to boundary (p < 0.001). There were also task by eyes condition interaction effects for anterior-posterior velocity and integrated time to boundary (p = 0.015 and p = 0.009, respectively). Increases in sway velocity and integrated time to boundary seen in the eyes condition and interaction effects are traditionally interpreted as poorer balance performance. However, in the context of stability/maneuverability tradeoff, the changes may indicate an increase in freedom of movement instead of a decrease in stability.
The data did not support a medication-induced improvement in automaticity, as measured by significant medication by task interactions. An alternate interpretation for medication-induced balance changes in PD includes an increase in maneuverability without sacrificing stability after taking dopaminergic medication.
研究表明,帕金森病(PD)患者的双任务站立平衡能力显著下降。此外,多巴胺能药物可改善动态平衡(伯格平衡量表、简易BESTest),但站立平衡(力平台姿势描记法)可能会受到影响。目前尚不清楚多巴胺能药物如何影响PD患者的站立平衡自动性。
多巴胺能药物能否改善PD患者在音素监测双任务期间的站立平衡自动性?
这是一项横断面研究。16名PD患者在停药和服药状态下分别完成睁眼和闭眼的单任务及双任务站立,各持续3分钟。计算95%置信椭圆面积、前后摆动速度、内外侧摆动速度和到达边界的累计时间。数据采用重复测量方差分析进行分析。
多巴胺能药物显著增加椭圆面积(p = 0.002),并降低次要任务的表现(p = 0.004)。不同的眼睛状态(睁眼与闭眼)显著增加了两种摆动速度(前后 = p < 0.001,内外侧 = p < 0.001),并增加了到达边界的累计时间(p < 0.001)。前后速度和到达边界的累计时间在任务与眼睛状态之间也存在交互作用(分别为p = 0.015和p = 0.009)。在眼睛状态及交互作用中观察到的摆动速度和到达边界的累计时间增加,传统上被解释为平衡表现较差。然而,在稳定性/机动性权衡的背景下,这些变化可能表明运动自由度增加,而非稳定性降低。
数据不支持药物诱导的自动性改善,这通过任务交互作用的显著药物效应来衡量。PD患者药物诱导的平衡变化的另一种解释是,服用多巴胺能药物后机动性增加而不牺牲稳定性。